tykhr
sign in
free sign up
Medicenna Therapeutics Corp
Biotechnology
Healthcare
MDNA
54.00 M shares
NASDAQ US
traded
08 Aug 2022
listed
yes
open
1.70
52 week high
3.94
high
1.88
52 week low
1.32
low
1.68
growth
-14.42 %
previous Close
1.70
P/E ratio
market cap
78.79 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
-3.21 M
33.31 %
eps
0.00 %
33.33 %
eps surprise
45.45 %
net profit margin
-320600000.00 %
0.00 %
operating incoming
-3.13 M
36.14 %
net change in cash
-2.86 M
-142.62 %
cash on hand
20.54 M
-12.21 %
cost of revenue
0.00 %
top